Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab to reduce periprosthetic bone resorption after total knee arthroplasty
2012-001285-15Phase 3Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Aseptic loosening (AL) comparing Denosumab (Prolia) with Placebo (2 arms). Primary endpoint: Changes in bone mineral density at 12 months. Started Jan 2013; status: completed.
02
Drugs
denosumab
03
Conditions
Aseptic loosening (AL)
Beyond the preview
Go deeper on 2012-001285-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001285-15.